Opportunities in Bridging the Gap Between Body & Device: Eliminating Complications
Tuesday, October 19, 2010 ~ 10:45 AM – 12:00 PM
Panel Location: 207B
Advances in medical technology and our aging population are fueling a rapid expansion in the use of medical device implants, a market that is predicted to double in the next ten years. While technology delivers substantial value and benefits to patient care, nearly half of all medical devices implanted in the body are plagued with one or more severe complications - such as infection, thrombosis, improper healing, and cell overgrowth. Device-related infection alone lengthens average hospital stays by approximately two weeks, costs up to $50,000 per patient to treat, and increases mortality by up to 25% - resulting in nearly $30 billion/yr in direct medical expenses. This panel explores the medical device industry view of this challenge, the opportunities presented in delivering complication-free products to the market, continued biomaterials innovation, and breakthrough technologies designed to reduce complications and healthcare costs. Panelists will discuss the changing regulatory and reimbursement environments associated with device complications, public and private research, the patient perspective and the market potential anticipated for a variety of indications and healthcare markets.
Moderator:
- Dr. Stephen Oesterle, MD, Sr. VP, Medicine & Technology, Medtronic, Inc.
Panelists:
- Dr. Justin Klein, MD, JD, Principal, New Enterprise Associates, Inc.
- Mr. David Lucchino, CEO, Semprus BioSciences
- Ms. Victoria Nahum, Executive Director, Safe Care Campaign
- Dr. John Jernigan, MD, MS, Director, Office of Prevention Research and Evaluation, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention
Testimonials
"The AdvaMed Conference provides unique access to key regulators, legislators and medical device industry leaders. The educational content is outstanding with expert and timely information that is critical in today’s rapidly changing healthcare environment. This truly is the most valuable conference of the year for those involved in the medical device industry."
Ernest Waaser, President Teleflex Medical